Clinical trials by condition
Acute myeloid leukemia (AML) clinical trials near you
286 studies for acute myeloid leukemia (AML) are recruiting volunteers at 1,514 research sites in 51 states.
Also called Acute myeloid leukaemia, AML.
A type of Leukemia
- Studies recruiting
- 286
- Research sites
- 1,514
- States
- 51
What is acute myeloid leukemia (AML)?
Acute myeloid leukemia (AML) is a cancer of the blood that starts in the bone marrow, the soft tissue inside bones that makes blood cells. In AML, the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells or platelets. "Acute" means it usually gets worse quickly if it is not treated. There are several subtypes, based on how developed the cancer cells are and how different they are from normal cells.
When the abnormal cells crowd out healthy cells, the result can be infection, anemia (too few red blood cells) and easy bleeding, and the abnormal cells can spread to other parts of the body. Signs include fever, shortness of breath, easy bruising or bleeding, tiny red dots under the skin, weakness or tiredness, weight loss and bone or joint pain.
AML is caused by changes in the genetic material (DNA) of bone marrow cells, and the cause of these changes is unknown. Risk is higher in men, in people who smoke, who have had chemotherapy or radiation, who were exposed to the chemical benzene, or who have another blood disorder such as myelodysplastic syndrome. It is found with blood tests, bone marrow tests and genetic tests. Treatment may include chemotherapy, radiation, a stem cell transplant and other anticancer medicines, often depending on the subtype.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 17, 2026. Read more on MedlinePlus
Areas with the most acute myeloid leukemia (AML) studies
Metro areas where studies for acute myeloid leukemia (AML) are recruiting, each study counted once in an area.
By state
Studies for acute myeloid leukemia (AML) recruiting in each state.
- Texas104 studies · 67 sites
- California82 studies · 118 sites
- New York74 studies · 86 sites
- Florida57 studies · 76 sites
- Ohio57 studies · 92 sites
- Massachusetts46 studies · 25 sites
- Pennsylvania46 studies · 44 sites
- Washington43 studies · 36 sites
- Georgia42 studies · 34 sites
- North Carolina42 studies · 54 sites
All 51 states
- Texas104
- California82
- New York74
- Florida57
- Ohio57
- Massachusetts46
- Pennsylvania46
- Washington43
- Georgia42
- North Carolina42
- Maryland34
- Tennessee34
- Illinois32
- Minnesota30
- New Jersey28
- Oregon28
- Wisconsin27
- Michigan26
- Colorado25
- Missouri25
- Arizona24
- Kansas23
- Virginia23
- Alabama16
- Iowa16
- Indiana16
- Kentucky16
- South Carolina16
- Utah16
- Oklahoma15
- Louisiana13
- Arkansas12
- Connecticut12
- Rhode Island12
- District of Columbia10
- Maine10
- Idaho9
- Nebraska8
- New Mexico8
- Mississippi7
- Montana7
- South Dakota7
- Vermont7
- West Virginia7
- Delaware6
- Hawaii6
- North Dakota4
- Nevada4
- Alaska2
- New Hampshire2
- Wyoming1
Whom the studies accept
The share of the acute myeloid leukemia (AML) studies open to each group. A study can accept several.
- Adults 18 to 6498%
- Adults 65 and over86%
- Children and teens (under 18)28%
- Healthy volunteers6%
- Open to all sexes100%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Early phase 11%
- Phase 142%
- Phase 1/214%
- Phase 223%
- Phase 2/32%
- Phase 33%
- Phase 41%
- No phase (device, behavioral and other studies)5%
- Not stated9%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Acute myeloid leukemia (AML) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/acute-myeloid-leukemia, updated November 17, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/acute-myeloid-leukemia">LocalTrial, Acute myeloid leukemia (AML) clinical trials near you</a>, updated November 17, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study acute myeloid leukemia (AML). A study is counted once however many sites it has.
Updated November 17, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the acute myeloid leukemia (AML) studies near you that may fit. Free and private.
Ready to see what's near you?
Find acute myeloid leukemia (AML) studies near me